We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Varian Medical Systems Earns Top Marks in Oncology IT Study

By HospiMedica staff writers
Posted on 07 Aug 2008
Print article
Varian Medical Systems, Inc. (Palo Alto, CA,USA) was ranked first in an independent study released last week by Klas (Orem, UT, USA), a research firm that specializes in monitoring and reporting on the performance of healthcare vendors. Varian's Aria software, an information system for managing medical and radiation oncology practices, received top scores in study categories including: ease of use, quality of releases and updates, and compatibility with third-party products.

According to the June 2008 Oncology report, Varian Medical Systems is "considered by many providers to have the most developed and comprehensive oncology solution." The report additionally stated, "many Varian customers feel that the Aria suite is the most robust solution for medical and radiation oncology available on the market today."

Although Klas interviewed 11 potential vendors, only three had a sufficient number of active installations to qualify. Varian was the only vendor to score above the group average in all four of the report's major categories: product/technology indicators, service indicators, success indicators, and business indicators. Varian scored above competitors in 23 of the 40 indicators that the study measured. Some of the indicators for which Varian achieved top scores included: ease of use; quality of releases or updates; technology that is easy to implement and support; works with third-party producers; quality of implementation, training, and documentation; quality and timeliness of interfaces; helping job performance, and overall satisfaction with vendor/product.

All of the CIOs, managers, doctors, nurses, information technology (IT) directors, and other administrators and healthcare professionals surveyed about their experience with Varian's oncology information system reported that they consider Varian's system part of their organization's long-term plan, that they would buy Varian's product again, and would recommend Varian's product to a friend or peer.

The Klas study predicted that Varian would continue to be seen as one of the most complete medical and radiation oncology systems for some time to come. "We're gratified to receive top marks in an objective survey of our customers," said Dow Wilson, president of the company's Oncology Systems business. "It validates the work we're doing to offer treatment centers a versatile set of best-in-class clinical tools for fighting cancer."

Varian Medical Systems is a world-leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers, and medical oncology practices. Varian is also a major supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications as well as X-ray imaging products for cargo screening and industrial inspection.

Klas is a research firm specializing in monitoring and reporting the performance of healthcare vendors.


Related Links:
Varian Medical Systems
Klas
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
New
Washer Disinfector
Tiva 2
New
Wound Care Cart
UMGKA-3669-LTG

Print article

Channels

Surgical Techniques

view channel
Image: Graphical abstract; Surgical field during endomyocardial biopsy and fluoroscopic images (Photo courtesy of Heart Rhythm, DOI: 10.1016/j.hrthm.2024.10.069)

Novel Method Combining Heart Biopsy and Device Implantation Reduces Complications Risk

Endomyocardial biopsy (EMB) is a crucial diagnostic tool for identifying various cardiac conditions; however, it carries a risk of complications due to its invasive nature. New research has introduced... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.